Cryoport, Inc.CYRXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
9.83%
↓ 42% below average
Average (39q)
17.05%
Historical baseline
Range
High:203.28%
Low:-51.95%
CAGR
-6.4%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 9.83% |
| Q2 2025 | 4.68% |
| Q1 2025 | -5.32% |
| Q4 2024 | -0.05% |
| Q3 2024 | -10.53% |
| Q2 2024 | -2.23% |
| Q1 2024 | 0.06% |
| Q4 2023 | -7.82% |
| Q3 2023 | 20.85% |
| Q2 2023 | 9.98% |
| Q1 2023 | -17.13% |
| Q4 2022 | 17.37% |
| Q3 2022 | 13.15% |
| Q2 2022 | -0.45% |
| Q1 2022 | -9.05% |
| Q4 2021 | -7.12% |
| Q3 2021 | -6.14% |
| Q2 2021 | 3.67% |
| Q1 2021 | 23.21% |
| Q4 2020 | 51.10% |
| Q3 2020 | 18.77% |
| Q2 2020 | 12.32% |
| Q1 2020 | 62.03% |
| Q4 2019 | -34.80% |
| Q3 2019 | 203.28% |
| Q2 2019 | 10.49% |
| Q1 2019 | -18.23% |
| Q4 2018 | 29.22% |
| Q3 2018 | 3.29% |
| Q2 2018 | 36.05% |
| Q1 2018 | -13.30% |
| Q4 2017 | 10.30% |
| Q3 2017 | 49.43% |
| Q2 2017 | -7.65% |
| Q1 2017 | 142.22% |
| Q4 2016 | -51.95% |
| Q3 2016 | 58.09% |
| Q2 2016 | -6.01% |
| Q1 2016 | -36.57% |
| Q4 2015 | 127.09% |